Research | DOI: https://doi.org/10.31579/2835-9291/35
Nutraceuticals in Liver Diseases*
- Rehan Haider *
- Hina Abbas
- Geetha Kumari Das
Department of Pharmacy University of Karachi Pakistan.
Assistant Professor Department of Pathology Dow University of Health Sciences.
GD Pharmaceutical Inc OPJS University Rajasthan India.
*Corresponding Author: Rehan Haider., Assistant Professor Department of Pathology Dow University of Health Sciences.
Citation: Haider R., Abbas H., Kumari Das G., (2025), Nutraceuticals in Liver Diseases”: International Journal of Clinical Case Studies.,4(4); DOI: 10.31579/2835-9291/35
Copyright: © 2025, Rehan Haider. This is an open access article distributed under the creative commons’ attribution license,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 10 June 2025 | Accepted: 09 July 2025 | Published: 21 July 2025
Keywords: nutraceuticals; liver diseases; hepatoprotection; antioxidants; silymarin; curcumin, nafld, functional foods; herbal compounds; liver health
Abstract
Liver afflictions are a primary worldwide strength concern, contributing considerably to depression and mortality. These afflictions, containing hepatitis, non-alcoholic fatty liver affliction (NAFLD), cirrhosis, and hepatocellular malignant growth, are often caused by circulating quickly infections, alcohol addiction, weak nutrition, corpulence, and material poisons. Conventional therapies are alive for affliction management, still they frequently come with reactions and restricted long-term influence. Consequently, nutraceuticals have acquired attention as hopeful completing, and supportive powers in liver affliction management on account of their organic inception, favorable security sketch, and multifaceted methods of operation. Nutraceuticals, which are bioactive compounds arising from feed and plant sources, contain polyphenols, flavonoids, silymarin, curcumin, glycyrrhizin, and end-3 fatty acids. These meanings exhibit effective antioxidant, anti-instigative, antifibrotic, and hepatoprotective characteristics. Their ability to adjust oxidative stress, restrict fibrogenesis, organize lipid metabolism, and better liver something which incites activity levels makes bureaucracy valuable in the stop and treatment of differing liver environments. Evidence from clinical and preclinical studies supports their function in lowering liver fat accumulation, restricting ailment progression, and reconstructing liver function. This review investigate the potential part of key nutraceuticals in managing liver afflictions, outlining their methods of action, security descriptions, and therapeutic pertinence. As liver ailments continue to pose meaningful community health challenges, nutraceuticals offer a supportive and deterrent approach alongside normal treatments. However, more exact dispassionate studies are needed to ratify optimum dosages, correct bioavailability, and assess enduring productiveness.
Introduction
Liver afflictions represent a meaningful all-encompassing health challenge, leading to nearly two million passing occurring worldwide [1]. These afflictions encompass an expansive range of environments, including aggressive hepatitis, alcoholic liver ailment (ALD), non-alcoholic fatty liver ailment (NAFLD), cirrhosis, and hepatocellular abnormal growth in animate being (HCC), many of which are incessant and growing in nature [2,3]. Factors to a degree obesity, motionless behaviors, poor digestive dresses, environmental poisons, and overdone alcohol devouring are major subscribers to hepatic dysfunction [4]. Despite progress in pharmacotherapy, the management of liver ailments remains suboptimal on account of restricted treatment alternatives, unfavorable drug reactions, and extreme costs [5,6]. In light of this, the role of completing and alternative medicine—particularly nutraceuticals—has collected increasing consideration in recent years [7]. Nutraceuticals are bioactive compounds that come from drink sources, that provide energy benefits further basic food, containing disease stop and healing effects [8]. These powers are known for their antioxidant, antagonistic-angering, antifibrotic, immunomodulatory, and hepatoprotective properties [9,10]. Prominent nutraceuticals intentional for liver afflictions include silymarin from milk prickle, curcumin from turmeric, glycyrrhizin from licorice root, resveratrol from crop, and omega-3 greasy acids from bait oils [11–13]. These agents have proved promising belongings in lowering liver enzyme levels, blocking lipid aggregation, enhancing mitochondrial function, and restricting fibrosis in two together clinical and preclinical studies [14]. However, despite these encouraging verdicts, further randomized regulated trials and patterned drug protocols are essential to reinforce their efficacy and security in the dispassionate management of liver ailments [15].
Research Method
A narrative review method was selected to evaluate the role of nutraceuticals in the stop and situation of liver afflictions. Relevant research was garnered from databases containing PubMed, Scopus, ScienceDirect, and Google Scholar, using keywords to a degree “nutraceuticals,” “liver ailments,” “hepatoprotection,” “silymarin,” “curcumin,” and “NAFLD.” Peer-inspected items written between 2000 and 2024 were contained. Both preclinical and dispassionate studies were deliberate, while studies in non-English dialects and those deficient scientific strictness were expelled. The focus act nutraceuticals accompanying manifested antioxidant, antagonistic-inflammatory, antifibrotic, and hepatoprotective features.
Results
A total of 58 studies were originally labeled, of which 32 joined the inclusion tests. Analysis disclosed that various nutraceuticals revealed hepatoprotective endeavors in animal models and human matters. Silymarin demonstrated a decline in liver catalyst levels (ALT, AST) and upgraded histological liver gravestones in victims with never-ending liver disease. Curcumin has shown antagonistic-angering effects in NAFLD by downregulating NF-κB indicating. Omega-3 greasy acids upgraded hepatic steatosis and insulin sympathy in NAFLD subjects. Glycyrrhizin and resveratrol still showed potential in lowering liver fibrosis and oxidative stress in miscellaneous models. However, skilled was instability in quantity, duration, and form of presidency across studies.
Discussion
The judgments imply that nutraceuticals can present an image of persuasive something that incites activity in the management of liver disorders. Silymarin’s antioxidative and sheet-fixing conduct help fix hepatic function, while curcumin’s antagonistic-inflammatory belongings weaken hepatocyte damage. Omega-3 greasy acids help the decline of hepatic lipid accumulation, which is exceptionally appropriate in metabolic liver ailments in the way that NAFLD [1–3]. Resveratrol and glycyrrhizin too exhibit antifibrotic properties, signifying potential in state-of-the-art liver fibrosis and cirrhosis administration [4,5]. Despite hopeful consequences, the clinical use of nutraceuticals remnants restricted on account of lacking big randomized reserved trials. Most existent studies are limited in sample amount and various in design. Moreover, the bioavailability of certain compounds, such as curcumin, the debris an important disadvantage [6]. There is further a lack of supervisory oversight in nutraceutical uniformity, that can impact thickness and healing consequences [7].
Conclusion
Nutraceuticals show a promising completing approach in liver ailment and the situation on account of their anti-angering, antioxidant, and hepatoprotective possessions. Key compounds like silymarin, curcumin, glycyrrhizin, and end-3 oily acids have proved potential benefits in two together preclinical and clinical backgrounds. However, further research is needed to decide patterned dosages, correct bioavailability, and evaluate general productiveness and security. Integrating nutraceuticals into liver ailment administration protocols manages embellished patient consequences when secondhand alongside unoriginal analyses.
Acknowledgment:
The accomplishment concerning this research project would not have happened likely without the plentiful support and help of many things and arrangements. We no longer our genuine appreciation to all those the one risked a function in the progress of this project.
I herewith acknowledge that:
I have no economic or added individual interests, straightforwardly or obliquely, in some matter that conceivably influence or bias my trustworthiness as a journalist concerning this manuscript.
Conflicts of Interest:
The authors declare that they have no conflicts of interest.
Financial Support and Protection:
No external funding for a project was taken to assist with the preparation of this manuscript
References
- Asrani SK, Devarbhavi H, Eaton J, Kamath PS. The burden of liver diseases on the planet. J Hepatol. 2019;70(1):151–171.
View at Publisher | View at Google Scholar - Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global community health of nonalcoholic oily liver ailment—Meta‐analytic evaluation of prevalence, occurrence, and effects. Hepatology. 2016;64(1):73–84.
View at Publisher | View at Google Scholar - Federico A, Dallio M, Loguercio C. Silymarin/silybin and never-ending liver ailment: a wedding of any age. Molecules. 2017;22(2):191.
View at Publisher | View at Google Scholar - Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: communication well-informed from dispassionate tests. AAPS J. 2013;15(1):195–218.
View at Publisher | View at Google Scholar - Yu J, Song Y, Guo X, Zhang W, Liu C. Effect of end-3 fatty acids on liver fat, redness, and fibrosis in NAFLD: an orderly review and meta-study. Clin Nutr. 2021;40(5):2458–2470.
View at Publisher | View at Google Scholar - Hewlings SJ, Kalman DS. Curcumin: A review of allure belongings on human fitness. Foods. 2017;6(10):92.
View at Publisher | View at Google Scholar - Cicero AF, Colletti A. Role of phytochemicals in the management of metabolic condition. Phytomedicine. 2016;23(11):1134–1144.
View at Publisher | View at Google Scholar - Patel SS, Shah RS, Goyal RK. Antioxidant and hepatoprotective belongings of herbaceous extracts and nutraceuticals: current healing potential. Indian J Physiol Pharmacol. 2011;55(3):249–267.
View at Publisher | View at Google Scholar - Kalra EK. Nutraceutical description and introduction. AAPS PharmSci. 2003;5(3):E25.
View at Publisher | View at Google Scholar - Liu J, Wang S, Zhang Y, Fan H. A review of the use of usual and completing cure in liver afflictions. Evid Based Complement Alternat Med. 2017;2017:8379392.
View at Publisher | View at Google Scholar - Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology. 2006;43(S1):S63–S74.
View at Publisher | View at Google Scholar - Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, and others. Vitamin E and end-3 oily acid-improved diets increase lineaments of NASH in children accompanying corpulence. J Pediatr. 2011;158(6):960–965.e1.
View at Publisher | View at Google Scholar - Kim HJ, Park DI, Park JH, Cho YK, Sohn CI, Jeon WK, and others. Randomized dispassionate trial: Korean coral ginseng improves liver function in cases accompanying raised alanine aminotransferase. Aliment Pharmacol Ther. 2012;35(4):560–568.
View at Publisher | View at Google Scholar - Loguercio C, Federico A. Oxidative stress in growing and alcoholic hepatitis. Free Radic Biol Med. 2003;34(1):1–10.
View at Publisher | View at Google Scholar - Stiuso P, Scognamiglio I, Miele C, and others. Serum levels of antioxidant vitamins and liver damage in subjects with incessant hepatitis C bacterium contamination. J Hepatol. 2014;60:S263.
View at Publisher | View at Google Scholar
Clinic